ID   240E-W
AC   CVCL_Z068
DR   Wikidata; Q54583426
RX   Patent=US10377814;
RX   PubMed=21633632;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
DI   NCIt; C133738; Rabbit plasmacytoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J972 ! 240E1-1-2
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
RX   Patent=US10377814;
RA   Pytela R., Zhu W.-M., Ke Y.-H., Qian Q., Au H.C.;
RT   "Fusion partner for production of monoclonal rabbit antibodies.";
RL   Patent number US10377814, 13-Aug-2019.
//
RX   PubMed=21633632; PMCID=PMC3102571;
RA   Feng L.-F., Wang X., Jin H.-C.;
RT   "Rabbit monoclonal antibody: potential application in cancer
RT   therapy.";
RL   Am. J. Transl. Res. 3:269-274(2011).
//